In a 17-0 vote, the US Food and Drug Administration (FDA) has recommended that the agency authorize the emergency use of Pfizer-BioNTech COVID-19 vaccine for children ages 5 through 11.
One member abstained from the vote.
The decision opens the door for final approval by the FDA, which could come as early as Wednesday, according to the Texas Tribune‘s Karen Brooks Harper.
The panel’s 17-0 vote, with one member abstaining, in favor of emergency use authorization for that age group opens the door for final approval by the FDA, which could come as early as Wednesday, by the FDA.
— Karen Brooks Harper (@kbrooksharper) October 26, 2021